Cargando…
Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation
Autores principales: | Xu, Xuefen, Zhang, Xiaobo, Zhang, Yi, Yang, Lin, Liu, Yicheng, Huang, Shaoliang, Lu, Lu, Kong, Lingyi, Li, Zhiyu, Guo, Qinglong, Zhao, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196212/ https://www.ncbi.nlm.nih.gov/pubmed/34117343 http://dx.doi.org/10.1038/s41598-021-91964-z |
Ejemplares similares
-
Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
por: Xu, Xuefen, et al.
Publicado: (2017) -
Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
por: Xu, Xuefen, et al.
Publicado: (2022) -
BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin
por: Xu, Xuefen, et al.
Publicado: (2016) -
Oroxyloside A Overcomes Bone Marrow Microenvironment-Mediated Chronic Myelogenous Leukemia Resistance to Imatinib via Suppressing Hedgehog Pathway
por: Zhang, Xiaobo, et al.
Publicado: (2017) -
Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment
por: Cao, Hanbo, et al.
Publicado: (2020)